SKI Market

Indian Indices

Nifty

26,175.75 -27.20
(-0.10%)

Sensex

85,641.90 -64.77
( -0.08%)

Bank Nifty

59,681.35 -71.35
( -0.12%)

Nifty IT

37,549.75 144.25
( 0.39%)

Global Indices

Nasdaq

47,737.43 289.30
(0.61%)

Dow Jones

6,869.48 35.87
(0.52%)

Hang Seng

49,313.21 -940.70
(-1.87%)

Nikkei 225

9,706.88 -13.63
(-0.14%)

Forex

USD-INR

89.30 0.10
(0.11%)

EUR-INR

103.54 0.22
(0.21%)

GBP-INR

118.23 0.49
(0.41%)

JPY-INR

0.57 0.00
(0.17%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500124

INE089A01031

377.5672424

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DRREDDY

19.45

105007.87

EPS(TTM)

Face Value()

Div & Yield %

64.68

0.64

Back

Arihant's Securities standalone net profit declines 78.26% in the June 2025 quarter

Jul 31,2025

Net profit of Arihant's Securities declined 78.26% to Rs 0.10 crore in the quarter ended June 2025 as against Rs 0.46 crore during the previous quarter ended June 2024. Sales declined 50.00% to Rs 0.01 crore in the quarter ended June 2025 as against Rs 0.02 crore during the previous quarter ended June 2024.

Particulars	Quarter Ended
	Jun. 2025	Jun. 2024	% Var.
Sales	0.01	0.02	-50
OPM %	1300.00	2300.00	-
PBDT	0.13	0.46	-72
PBT	0.13	0.46	-72
NP	0.10	0.46	-78

26,175.75 -27.20 (-0.10%)

85,641.90 -64.77 ( -0.08%)

59,681.35 -71.35 ( -0.12%)

37,549.75 144.25 ( 0.39%)

47,737.43 289.30 (0.61%)

6,869.48 35.87 (0.52%)

49,313.21 -940.70 (-1.87%)

9,706.88 -13.63 (-0.14%)

89.30 0.10 (0.11%)

103.54 0.22 (0.21%)

118.23 0.49 (0.41%)

0.57 0.00 (0.17%)